Understanding IVF Success Rates: How They Are Measured

Medically reviewed on 18 June 2026 - Dr. Senai Aksoy

Key Takeaways

IVF success rates are reported in several different ways — per cycle started, per egg retrieval, per embryo transfer, and cumulatively across transfers — so two clinics can quote very different numbers for the same patient. European registry data (ESHRE/EIM) put the pregnancy rate at roughly a third per fresh transfer, with outcomes falling steadily after the late thirties. The most honest figure is an individual estimate based on age, ovarian reserve, sperm parameters and prior history, not a single headline percentage.

When patients ask me, “Doctor, what is your success rate?”, I understand exactly what they are hoping for: one clear number they can hold on to. I wish the answer were that simple. It is one of the most reasonable questions in fertility care, and also one of the easiest to answer in a misleading way.

The truth is that “IVF success rate” is not a single figure. It is a family of different measurements. The number a clinic puts on its website can change a great deal depending on which measurement it picks, who it counts, and which patients are included. Before you compare clinics or plan treatment, it helps to understand what these numbers actually describe — and, just as importantly, what they cannot tell you about your own case.

Why IVF Success Rates Are Not a Single Number

There is no universal “success rate” because success can be measured at several different points in the treatment journey, and each gives a different figure.

The same cycle can be reported as a rate per cycle started, per egg retrieval, per embryo transfer, or cumulatively across several transfers from one retrieval. A pregnancy rate per transfer always looks higher than a rate per cycle started, simply because cycles that never reached transfer have been removed from the calculation.

There is also a difference between a pregnancy rate and a live birth rate. A positive pregnancy test is not the same as a baby born at home. Live birth rate is the figure that matters most to patients, yet pregnancy rate — the higher number — is the one more often shown first.

The questions worth asking are practical ones: Is this number per transfer or per cycle started? Is it pregnancy or live birth? Which age group does it describe? Without those three answers, a percentage on its own tells you very little.

How Clinics Report Outcomes — and What to Compare

To compare two clinics fairly, you have to make sure they are measuring the same thing, in the same way, for similar patients.

Several reporting choices change the headline figure:

If a number is not age-stratified, treat it with caution. A clinic that treats mostly younger patients will show a higher average than one that takes on complex, older, or previously unsuccessful cases — without being any better at the medicine.

What European Registry Data Show

Across Europe, the pregnancy rate is roughly one third per fresh embryo transfer, and it declines steadily with maternal age.

The European IVF Monitoring Consortium (EIM), coordinated by ESHRE, collects data from well over a thousand clinics across roughly 40 European countries — one of the largest fertility datasets in the world. In its full report on 2019 cycles, the pregnancy rate per fresh transfer was about 34.6% for IVF and 33.5% for ICSI, with delivery rates per transfer of roughly 25.3% and 24.1%. Frozen transfers reported a pregnancy rate of about 35.8% and a delivery rate of about 25.6% per transfer. More recent figures presented for 2022 cycles were broadly stable, with pregnancy rates near 32–33% per fresh transfer and about 37% per frozen transfer.

Measure (European registry, per transfer)IVFICSIFrozen transfer
Pregnancy rate~34.6%~33.5%~35.8%
Delivery rate~25.3%~24.1%~25.6%

Source: ESHRE/EIM report on 2019 cycles, the most recent full peer-reviewed dataset. All figures are per embryo transfer, 2019 cycles. They are European averages across many clinics, not specific to any single centre.

These averages hide a strong age effect. The same report noted that delivery rates in women aged 40 and older spanned a very wide range depending on the exact age and treatment, falling into the low single digits at the older end. That is the most important pattern in the entire dataset: outcomes do not fall off a cliff at one birthday, but they decline meaningfully through the late thirties and early forties.

A US Benchmark for Context

US national data tell the same story through a different lens, reporting outcomes per egg retrieval rather than per transfer.

The Society for Assisted Reproductive Technology (SART) publishes national figures for the United States. For 2022, the live birth rate per intended egg retrieval — which counts a live birth from any transfer arising from one retrieval, close in spirit to a cumulative measure — fell clearly with age:

Maternal ageLive birth rate per intended egg retrieval (US, 2022)
Under 35~43%
35–37~31%
38–40~19%
41–42~11%
Over 42~3%

Source: SART national summary, 2022 cycles. Per intended egg retrieval, own (non-donor) eggs. Methodology differs from European per-transfer reporting, so the two tables are not directly interchangeable.

The European and US systems define and group their data differently, so you cannot place the two tables side by side and declare one region “better”. What they agree on is the trajectory: the strongest single predictor of an IVF outcome is the age of the eggs.

What Actually Moves the Odds for One Patient

A registry average describes a population. Your own prognosis depends on a handful of specific, measurable factors.

The main ones I weigh in consultation are:

No two patients with the same age have the same prognosis once these factors are accounted for. This is why a personalised estimate is more useful than any published average, and why I am cautious about quoting a single number before I have seen the full clinical picture.

What Your Consultation Should Cover

A useful consultation replaces the headline percentage with a realistic, individual estimate and a plan.

When we review a case together, the conversation should cover a realistic outcome range for your specific situation, how many cycles might reasonably be needed when we think in cumulative terms, the rationale behind the medication protocol we would choose, and what the step-by-step IVF process involves. Because more than one cycle is sometimes part of a realistic plan, it is fair to discuss the cost of treatment across that horizon rather than per attempt. Where relevant, we also discuss options such as donor gametes — not as a sales pitch, but so that the full landscape is clear.

The Limits of Registry Data

Even the best registry figures describe groups, not individuals, and they carry built-in limitations.

A few are worth keeping in mind. Clinics report the cycles they participate in, which can introduce selection effects. Patients within the same age band are not clinically identical. And there is an unavoidable time lag — the most complete reports describe cycles from a few years earlier, because the data take time to collect, verify, and publish. None of this makes registries unreliable; it simply means they are a backdrop for your individual prognostic assessment, not a substitute for it.

Frequently Asked Questions

Is a higher “pregnancy rate” the same as a higher chance of a baby?

No. Pregnancy rate counts positive pregnancy tests or clinical pregnancies, while live birth rate counts babies born. Live birth rate is always lower and is the figure that matters most when you compare options.

Why does one clinic quote a much higher success rate than another?

Often it is a difference in measurement, not medicine. A clinic quoting per-transfer numbers, or treating mostly younger patients, will show higher averages than one reporting per cycle started or taking on complex cases. Always check the denominator and the age group.

What is a cumulative live birth rate?

It is the chance of a live birth across all embryo transfers — fresh and frozen — that come from a single egg retrieval. It reflects the full value of one stimulation cycle and is increasingly seen as the most meaningful way to discuss realistic chances.

How much does age really affect IVF success?

A great deal. Both European and US registry data show outcomes declining steadily from the late thirties onward, with the sharpest fall after age 40, because egg quality and quantity change with age. Age is the single strongest predictor of an IVF outcome.

Can you tell me my personal success rate before treatment?

I can give a realistic estimate once I have reviewed your age, ovarian reserve, sperm parameters, and history — but not a guarantee. A personalised range based on your own results is far more useful than any clinic-wide average.

Clinical Note

In more than thirty years of practice, I have noticed that the patients who feel most in control are not the ones chasing the highest advertised percentage. They are the ones who understand which number actually applies to them. The figure I care about in consultation is never the one on a brochure; it is the realistic estimate for your age, your ovarian reserve, and your history, looked at across the cycles it may take rather than a single attempt. That is exactly the conversation we have when we sit down together.

— Dr. Senai Aksoy

Request a Case Review

If you would like a realistic, individual assessment rather than a headline number, you can request a confidential case review. Sharing your age, prior test results, and any previous treatment history helps us give you a meaningful estimate from the start.

Medical Disclaimer

This article is for general educational purposes and reflects published registry data and clinical experience. It does not constitute an individual diagnosis, a treatment recommendation, or any promise of a specific outcome. Success rates vary between individuals, and only a personal evaluation can estimate your own chances.

References

  1. Smeenk J, Wyns C, De Geyter C, et al. ART in Europe, 2019: results generated from European registries by ESHRE. Human Reproduction. 2023;38(12):2321–2338. doi:10.1093/humrep/dead197
  2. Wyns C, et al. ART in Europe, 2020: results generated from European registries by ESHRE. Human Reproduction. 2025. doi:10.1093/humrep/deaf179
  3. European Society of Human Reproduction and Embryology (ESHRE). ART Fact Sheet. https://www.eshre.eu/Press-Room/Resources
  4. Society for Assisted Reproductive Technology (SART). National Summary Report, 2022. https://www.sartcorsonline.com/rptcsr_publicmultyear.aspx
  5. ESHRE / Focus on Reproduction. IVF and IUI pregnancy rates remain stable across Europe (2022 data, 41st Annual Meeting). https://www.focusonreproduction.eu/

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.